Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AMIFAMPRIDINE PHOSPHATE, with a corresponding US DMF Number 34624.
Remarkably, this DMF maintains an Active status since its submission on February 29, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 08, 2022, and payment made on June 14, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II